TORONTO, April 22, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF) is pleased to announce it has received its oil sales licence from Health Canada pursuant to the Cannabis Act for its Hamilton, Ontario facility.
The Company received its oils production licence in April of 2018 and subsequently installed a state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils. The process is free of toxic solvents and does not require any winterization protocol. The result of this specialized extraction process is a precisely concentrated, aromatic golden-brown oil that is as close to the original plant composition as can be achieved. TGOD's premium cannabis products, including its cannabis oils, are certified organic by ProCert and its innovative growing process is certified organic by both ProCert and Ecocert, producing a clean, high-quality end product.
TGOD's oil extraction facility was built to GMP (Good Manufacturing Practices) specifications, and work is currently underway for European Union GMP ("EU-GMP") certification, which will allow the Company to expand distribution of its certified organic cannabis oils beyond Canada to global markets.
"We are pleased to offer TGOD's medical patients access to new premium certified organic cannabis oils," said Brian Athaide, TGOD CEO. "In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready," continued Athaide.
TGOD's oils will be as close to the original plant as possible, including terpene profiles to realize entourage effects. The process is easily customizable to create full-spectrum strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations.
"Oil is predominantly a medical product, and patients want clean, organic efficacy with safe and easy delivery," said Dr. Rav Kumar, Chief Science Officer of TGOD. "Through our certified organic product and process we know we are providing patients the best possible experience."
In March, the first group of patients, the Growers' Circle, received access to purchase TGOD's first certified organic cannabis strain through the website and the feedback has been extremely positive from all across the country. TGOD's Unite Organic Cannabis Oil, derived from a high-potency THC-dominant strain, will begin shipping later this month.
To sign up for the Unite Organic waitlist, please visit TGOD's patient center at TGOD.ca or call 905-304-4201.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD's products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
TGOD's Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol "TGOD" and "TGOD.WT", respectively.
For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about EU-GMP certification, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, revenue, export capabilities and cashflows, statements about the offering or efficacy of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.